153Sm-EDTMP With or Without a PSA/TRICOM Vaccine To Treat Men With Androgen-Insensitive Prostate Cancer

NCT00450619 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

NIH

Sponsor class

Conditions

Prostate Cancer

Interventions

RADIATION: Samarium Sm 153 lexidronam pentasodium
BIOLOGICAL: Sargramostim
BIOLOGICAL: Recombinant vaccinia-TRICOM vaccine
BIOLOGICAL: Recombinant fowlpox-TRICOM vaccine

Sponsor

National Cancer Institute (NCI)